Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-22-021197
Filing Date
2022-08-03
Accepted
2022-08-03 17:26:50
Documents
2
Group Members
3E BIOVENTURES GP GP, LLC3E BIOVENTURES GP, L.P.BC DCYTO LTDQIANYE KAREN LIU

Document Format Files

Seq Description Document Type Size
1 formsc13ga.htm SC 13G/A 177386
2 ex99-1.htm EX-99.1 19843
  Complete submission text file 0001493152-22-021197.txt   199064
Mailing Address 47215 LAKEVIEW BOULEVARD FREMONT CA 94538
Business Address 47215 LAKEVIEW BOULEVARD FREMONT CA 94538 (877) 922-9835
Cytek Biosciences, Inc. (Subject) CIK: 0001831915 (see all company filings)

EIN.: 472547526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92754 | Film No.: 221133761
SIC: 3826 Laboratory Analytical Instruments

Mailing Address SUITE 701 TOWER C TSINGHUA SCIENCE PARK NO. 1 ZHONGGUANCUN EAST ROAD, HAIDIAN BEIJING F4 100084
Business Address SUITE 701 TOWER C TSINGHUA SCIENCE PARK NO. 1 ZHONGGUANCUN EAST ROAD, HAIDIAN BEIJING F4 100084 8613811460182
3E Bioventures Capital, L.P. (Filed by) CIK: 0001911673 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A